Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 9, 1996, Pages 699-703

  Giusti, Ruthann M ^a   Maloney, Elizabeth M ^a   Hanchard, Barrie ^b   Morgan, Owen St Claire ^b   Steinberg, Seth M ^a   Wachter, Helmut ^c   Williams, Elaine ^b   Cranston, Beverly ^b   Fuchs, Dietmar ^c   Manns, Angela ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF THE WEST INDIES   (Jamaica)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; KYNURENINE; NEOPTERIN; TRYPTOPHAN;

ARTICLE; CANCER IMMUNOLOGY; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOSTIMULATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SPASTIC PARAPLEGIA; T CELL LEUKEMIA; T CELL LYMPHOMA;

ADULT; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; BIOPTERIN; CROSS-SECTIONAL STUDIES; FEMALE; FORECASTING; HTLV-I ANTIBODIES; HUMANS; JAMAICA; KYNURENINE; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MIDDLE AGED; NEOPTERIN; PARAPARESIS, TROPICAL SPASTIC; PILOT PROJECTS; PROPORTIONAL HAZARDS MODELS; SEROEPIDEMIOLOGIC STUDIES; SURVIVAL RATE; TRYPTOPHAN;

EID: 16044371586     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Blattner, W. A. Human T-cell lymphotropic viruses and cancer causation. In: V. T. Devita, Jr., S. Helman, and S. A. Rosenberg (eds.). Cancer Prevention, pp. 1-20. Philadelphia: J. B. Lippincott Company, 1993.
2. Gessain, A., Barin, F., Vemant, J. C., Gout, O., Maurs, L., Calender, A., and de The, G. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet, 2: 407-410, 1985.
3. Rodgers-Johnson, P, Gajdusek, D. C., Morgan, O. S. C., Zaninovic, V., Sarin, P. S., and Ghaham, D. S. HTLV-I and HTLV-III antibodies and tropical spastic paraparesis. Lancet, 2: 1247-1248, 1985.
4. Tendier, C. L., Greenberg, S. J., Burton, J. D., Danielpour, D., Kim, S. J., Blattner, W. A., Manns, A., and Waldmann, T. A. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis. J. Cell. Biochem., 46: 302-311, 1991.
5. Lee, H. H., Swanson, P., Rosenblatt, J. D., Chen, I. S. Y., Sherwood, W. C., Smith, D. E., Tegtmeier, G. E., Fernando, L. P., Fang, C. T., Osame, M., and Kleinman, S. H. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet, 337: 1435-1439, 1991.
6. Murphy, E., Hanchard, B., Figueroa, J. P., Gibbs, W. N., Lofters, W. S., Campbell, M., Goedert, J. J., and Blattner, W. A. Modeling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int. J. Cancer, 43: 250-253, 1989.
7. Kaplan, J. E., Osame, M., Kubota, H., Igata, A., Nishitani, H., Maeda, Y., Khabbaz, R. F., and Janssen, R. S. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquired Immune Defic. Syndr., 3: 1096-1101, 1990.
8. Kramer, A., Biggar, R. J., Hampl, H., Friedman, R. M., Fuchs, D., Wachter, H., and Goedert, J. J. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific. Am. J. Epidemiol., 136: 71-80, 1992.
9. Murphy, E. L., Figueroa, J. P., Gibbs, W. N., Holding-Cobham, M., Cranston, B., Malley, K., Bodner, A. J., Alexander, S. S., and Blattner, W. A. Human T-lymphotropic virus type I (HTLV-I) seroprevalcnce in Jamaica. I. Demographic determinants. Am. J. Epidemiol., 133: 1114-1124, 1991.
10. Kramer, A., Maloney, E. M., Morgan, O. S. C., Rodgers-Johnson, P., Manns, A., Murphy, E. L., Larsen, S., Cranston, B., Murphy, J., Benichou, J., and Blattner, W. A. Risk factors and cofactors for human T-cell lymphotropic virustype I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica. Am. J. Epidemiol., 142: 1212-1220, 1995.
11. Manns, A., Cleghorn, F. R., Falk, R. T., Hanchard, B., Jaffe, E. S., Bartholomew, C., Hange, P., Benichou, J., Blattner, W. A., and the HTLV Lymphoma Study Group. Role of HTLV-I in development of non-Hodgkin Lymphoma in Jamaica and Trinidad and Tobago. Lancet, 342: 1447-1450, 1993.
12. Gasse, T., Murr, C., Meyersbach, P., Schmutzherd, E., Wachter, H., and Fuchs, D. Neopterin production and tryptophan degradation in acute Lyme neuroborreliosis versus late Lyme encephalopathy. Eur. J. Clin. Chem. Clin. Biochem., 32: 685-689, 1994.
13. Kaplan, E., and Meier, P. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
14. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
15. Cox, D. Regression models and life tables. J. R. Stat. Soc. [B]., 34: 187-202, 1972.
16. Wachter, H., Fuchs, D., Hausen, A., Reibnegger, G., Weiss, G., Werner, E. R., and Werner-Felmayer, G. Biosynthesis of pteridines and the human immune system. Neopterin: Biochemistry-Methods-Clinical Application, pp. 33-54. Berlin: Walter de Gruyter, 1992.
17. Peterson, P. A., Rask, L., and Lindblom, B. Highly purified papain-solubilised HL-A antigens contain beta-2-microglobulin. Proc. Natl. Acad. Sci., 71: 35-39, 1974.
18. Child, J. A., and Kushwara, M. A. S. Human beta-2-microglobulin in lymphoproliferative and myeloproliferative diseases. Hematol. Oncol., 2: 391-401, 1984.
19. Melillo, L., Musto, P., Tomasi, P., Cascavilla, N., Bodenizza, C., Ladogana, S., and Carotenuto, M. Serum beta-2-microglobulin in malignant lymphoproliferative disorders. Tumori, 74: 129-135, 1988.
20. Sönnerborg, A. B., von Stedingk, L. V., Hansson, L. O., and Strannegård, O. O. Elevated neopterin and beta-2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infection. AIDS (Phila.), 3: 277-283, 1989.
21. Lamelin, J., Vincent, C., Fontaine-Legrand, C., and Revillard, J. Elevation of serum-β2-microglobulin during infectious mononucleosis. Clin. Immunol. Immunopathol., 24: 55-62, 1982.
22. 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection. Infection, 19: S98-S102, 1991.
23. Wibell, L., Evrin, P. E., and Beggard, J. Serum β2-microglobulin in renal disease. Nephron, 10: 320-331, 1973.
24. Werner, E. R., Bitterlich, G., Fuchs, D., Hausen, A., Reibnegger, G., Szabo, G., Dierich, M. P., and Wachter, H. Human macrophages degrade tryptophan upon induction by interferon-gamma. Life Sci., 41: 273-280, 1987.
25. 2-microglobulin in patients with adult T-cell leukemia. Acta Haematol. (Basel), 86: 31-35, 1991.
26. Jacobson, S., Zaninovic, V., Mora, C., Rodgers-Johnson, P., Sheremata, W. A., Gibbs, C. J-, Gajdusek, D. C., and McFarlin, D. E. Immunologic findings in neurological diseases associated with antibodies to HTLV-I-activated lymphocytes in tropical spastic paraparesis. Ann. Neurol., 23 (Suppl.): S196-S200, 1988.
27. Ali, A., Rudge, P., and Dalgleish, A. G. Neopterin concentrations in serum and cerebral spinal fluid in HTLV-I infected individuals. J. Neurol., 259: 270-272, 1992.
28. Fuchs, D., Moller, A. A., Reibnegger, G., Stockle, E., Werner, E. R., and Wachter, H. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J. Acquired Immune Defic. Syndr., 3: 873-876, 1990.
29. Fuchs, D., Forsman, A., Hagberg, L., Larsson, M., Norkrans, G., Reibnegger, G., Werner, E. R., and Wachter, H. Immune activation and decreased tryptophan in patients with HIV-1 infection. J. Interferon Res., 10: 599-603, 1990.
30. Strickler, H. D., Escoffery, C., Rattray, C., Fuchs, D., Wachter, H., Manns, A., Schiffman, M. H., Cranston, B., Hanchard, B., and Blattner, W. A. Cervical intraepithelial neoplasia is not associated with elevated serum neopterin levels. Cancer Epidemiol., Biomarkers & Prev., 4: 295-298, 1995.
31. Tsoukas, C. M., and Bernard, N. F. Markers predicting progression of human immunodeficiency virus-related disease. Clin. Microbiol. Rev., 7: 14-28, 1994.
32. Diamondstone, L. S., Tollerud, D. J., Fuchs, D., Wachter, H., Brown, L. M., Maloney, E., Kurman, C., Nelson, D. L., and Blattner, W. A. Factors influencing serum neopterin and β2-microglobulin levels in a healthy diverse population. J. Clin. Immunol., 14: 368-374, 1994.